Clinical Trials
6 trialsNCT07405099 2026-02-27
Operative Risk After Pancreatic Surgery in Patients With End Stage Renal Disease
National Taiwan University Hospital
Enrolling by invitation
NCT06909968 2025-12-03
Identification of Palliative Care Needs and Prognostic Factors of Survival in Tailoring Appropriate Interventions in Advanced Oncological, Renal and Pulmonary Diseases
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Completed
NCT05977387 2023-08-04
PeKiT
Imagine Institute
Unknown
NCT03356340 2021-08-20
SCHS
Duke-NUS Graduate Medical School
Unknown
NCT00904579 2020-04-28
Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease
National Institutes of Health Clinical Center (CC)
Completed
NCT01273597 2013-01-18
Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands
AbbVie
Completed